AKT1 and metabolic dysfunction-associated steatotic liver disease: The same phosphorylation site is widely investigated in the literature to observe mTORC1 activation in NAFLD models [27,28], and HFD administration generally results in a significant activation of Akt and further increased mTOR phosphorylation at Ser2448 [28].